Canada Pension Plan Investment Board
KROS icon

Canada Pension Plan Investment Board’s Keros Therapeutics KROS Stock Holding History

Canada Pension Plan Investment Board’s Portfolio KROS Stock Details KROS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$487K Hold
44,100
– – ﹤0.01% 1239
2025
Q4 		$898K Sell
44,100
-183,200
-81% -$3.21M ﹤0.01% 1103
2025
Q3 		$3.6M Sell
227,300
-91,100
-29% -$1.35M ﹤0.01% 807
2025
Q2 		$4.25M Buy
+318,400
New +$4.3M ﹤0.01% 734

Other funds holding KROS

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
NCM
Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
Qube Research & Technologies (QRT)
Qube Research & Technologies (QRT) London, United Kingdom $89.9B AUM 20.22% 1-Year Est. Return
Jacobs Levy Equity Management
Jacobs Levy Equity Management Florham Park, New Jersey $23.8B AUM 25.4% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
MAP
Madison Avenue Partners New York $2.3B AUM 115.82% 1-Year Est. Return

Canada Pension Plan Investment Board's KROS Position: Q1 2026 in Review

Canada Pension Plan Investment Board held its Keros Therapeutics (KROS) position steady in Q1 2026 at 44,100 shares worth $487K. The position accounts for ﹤0.01% of the portfolio, ranked #1239.

Canada Pension Plan Investment Board first reported a position in KROS in Q2 2025 and has held it in 4 quarters since. The position peaked at $4.25M in Q2 2025. 151 funds tracked by Wall St. Rank hold KROS as of Q1 2026.

  • Canada Pension Plan Investment Board held 44,100 shares of Keros Therapeutics worth $487K as of Q1 2026.
  • Canada Pension Plan Investment Board left its Keros Therapeutics share count unchanged in Q1 2026.
  • Keros Therapeutics made up ﹤0.01% of Canada Pension Plan Investment Board's portfolio in Q1 2026, its #1239 holding.
  • Canada Pension Plan Investment Board first reported a position in Keros Therapeutics in Q2 2025 and has held it in 4 quarters since.
  • Canada Pension Plan Investment Board's Keros Therapeutics position peaked at $4.25M in Q2 2025.
  • 151 funds tracked by Wall St. Rank held Keros Therapeutics as of Q1 2026.

Based on Canada Pension Plan Investment Board's 13F filing for Q1 2026, filed 15 May 2026.